Name: Zhengye Biotechnology Holding Limited (ZYBT) Financial Statements
Creator: FinSpry

Zhengye Biotechnology Holding Income Statement Analysis

Revenue, earnings, and profit margins in millions CNY

Scale:

Scroll to see more

Zhengye Biotechnology Holding Limited income statement - Annual data in millions CNY
Breakdown	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 2024	Dec 2023	Dec 2022	Dec 2021
Revenue & Gross Profit
Revenue	186.36	211.65	260.27	214.07
Cost of Revenue	95.06	94.14	112.39	89.45
Gross Profit	91.30	117.51	147.88	124.62
Operating Expenses
Research & Development	12.79	11.90	13.42	11.37
Selling, General & Administrative	63.84	64.34	58.89	58.86
Operating Expenses	74.86	69.87	81.79	72.16
Operating Income	16.44	47.64	66.09	52.47
Other Income/Expense
Interest Income	0.23	0.31	0.11	0.11
Interest Expense	4.04	4.42	2.84	-1.05
Other Income/Expense	-2.05	0.23	0.55	1.62
Income
Income Before Tax	14.39	43.76	63.91	53.07
Income Tax Expense	0.92	6.25	8.17	6.60
Net Income	11.31	31.46	46.74	38.96
Net Income - Continuous Operations	11.31	37.51	55.74	46.47
Net Income - Discontinued Operations	0.00	0.00	0.00	0.00
EBITDA	42.60	72.10	85.55	68.48
EBIT	16.44	48.19	66.75	52.47
Depreciation & Amortization	24.16	23.91	18.80	16.01
Earnings Per Share
Basic EPS	-	1.00	1.00	1.00
Diluted EPS	-	1.00	1.00	1.00
Basic Shares Outstanding	0.00	45.67	45.67	45.67
Diluted Shares Outstanding	0.00	47.17	47.17	45.67